首页> 外国专利> Preparation of dialkylaminothiophenecarboxylic acid derivative as intermediate for renalic acid involves reacting aminothiophenecarboxylic acid with carboxyalkyl bromide in presence of quaternary ammonium compound of eight to ten carbons

Preparation of dialkylaminothiophenecarboxylic acid derivative as intermediate for renalic acid involves reacting aminothiophenecarboxylic acid with carboxyalkyl bromide in presence of quaternary ammonium compound of eight to ten carbons

机译:制备作为肾脏酸中间体的二烷基氨基噻吩羧酸衍生物涉及在8至10个碳原子的季铵化合物存在下使氨基噻吩羧酸与羧烷基溴反应

摘要

Preparation of 3-alkoxycarbonylmethyl-4-cyano-5-(N,N-bis(carboxyalkyl))aminothiophene-2-carboxylic acid derivatives (I) involves reaction of 3-alkoxycarbonylmethyl-4-cyano-5-amino-thiophene-2-carboxylic acid (II) with alkoxycarbonylalkyl bromide in presence of quaternary ammonium compound and potassium carbonate at reflux of an organic solvent, followed by filtration, cooling and drying. Preparation of 3-alkoxycarbonylmethyl-4-cyano-5-(N,N-bis(carboxyalkyl))aminothiophene-2-carboxylic acid derivatives of formula (I) involves: (1) reacting 3-alkoxycarbonylmethyl-4-cyano-5-amino-thiophene-2-carboxylic acid of formula (II) with alkoxycarbonyl alkyl bromide of formula Br-CH2-C(O)OR' (III) in the presence of 8-10C type quaternary ammonium compound of formula R1R2R3R4-N+X- and potassium carbonate at reflux of an organic solvent; (2) filtrating the reaction mixture; (3) concentrating the mixture by distillation; (4) adding a co-solvent; (5) cooling and filtering the reaction mixture; and (6) drying to form a powder. R and R' = linear or branched 1-6C alkyl; R1 = 1-6C alkyl; R2 - R4 = 8-10C alkyl; and X = halo. Independent claims are included for the following: (1) synthesis of ranelic acid, its strontium, calcium or magnesium salt or hydrate of the salt from (I); and (2) new methyl 5-(bis(2-methoxy-2-oxoethyl)amino)-4-cyano-3-(2-methoxy-2-oxoethyl)-2-thiophenecarboxylate and methyl 5-(bis(2-ethoxy-2-oxoethyl)amino)-4-cyano-3-(2-methoxy-2-oxoethyl)-2-thiophenecarboxylate.
机译:3-烷氧基羰基甲基-4-氰基-5-(N,N-双(羧烷基))氨基噻吩-2-羧酸衍生物的制备(I)涉及3-烷氧基羰基甲基-4-氰基-5-氨基-噻吩-2的反应在季铵化合物和碳酸钾的存在下,在有机溶剂的回流下,用烷氧基羰基烷基溴与α-羧酸(II),然后过滤,冷却和干燥。式(I)的3-烷氧基羰基甲基-4-氰基-5-(N,N-双(羧烷基))氨基噻吩-2-羧酸衍生物的制备涉及:(1)使3-烷氧基羰基甲基-4-氰基-5-反应在式R1R2R3R4-N + X的8-10C型季铵化合物存在下,式(II)的氨基-噻吩-2-甲酸与式Br-CH2-C(O)OR'(III)的烷氧基​​羰基烷基溴-和碳酸钾在有机溶剂回流下; (2)过滤反应混合物; (3)通过蒸馏浓缩混合物; (4)添加助溶剂; (5)冷却并过滤反应混合物; (6)干燥成粉末。 R和R′=直链或支链1-6C烷基; R1 = 1-6C烷基; R2-R4 = 8-10C烷基; X =晕以下内容包括独立权利要求:(1)从(I)合成雷诺酸,其锶,钙或镁盐或盐的水合物; (2)新的5-(双(2-(2-甲氧基-2-氧乙基)氨基)-4-氰基-3-(2-甲氧基-2-氧乙基)-2-噻吩甲酸甲酯和5-(双(2-乙氧基-2-氧代乙基)氨基)-4-氰基-3-(2-甲氧基-2-氧代乙基)-2-噻吩羧酸酯。

著录项

  • 公开/公告号IS2728B

    专利类型

  • 公开/公告日2011-04-15

    原文格式PDF

  • 申请/专利权人 LES LABORATOIRES SERVIER;

    申请/专利号IS20050007803

  • 申请日2005-04-18

  • 分类号C07D333/38;A61K;C07B45;C07B61;C07D;C07D295;C07D333/26;C07D333/36;C07D333/70;C07K5/06;

  • 国家 IS

  • 入库时间 2022-08-21 18:05:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号